高级搜索

回药爱康方抗C57小鼠肺癌转移及影响bcl-2的表达

Effects of Hui Medicine Aikangfang on Metastasis and bcl-2 Expression of Lung Cancer in C57 Mice

  • 摘要: 目的 观察回药爱康方对C57小鼠Lewis肺癌细胞转移的影响,并检测各组小鼠瘤组织bcl-2的表达。方法将55只C57荷瘤小鼠随机分为荷瘤模型组,环磷酰胺(CTX)组,回药爱康方低剂量组、回药爱康方低剂量加化疗组、回药爱康方高剂量加化疗组。治疗后,观察各组小鼠肺表面转移灶和bcl-2蛋白的表达情况。结果(1) 肺转移灶的变化:与荷瘤模型组比较,其余各组小鼠肺转移灶差异有统计学意义(P<0.05)。(2)bcl-2表达情况:与荷瘤模型组比较,其余各组bcl-2的表达差异有统计学意义(P<0.01)。结论回药爱康方有抗小鼠肺癌转移和降低bcl-2表达的作用。

     

    Abstract: Objective To observe metastatic effect of Hui medicine Aikangfang in C57 mice Lewis lung cancer cells and test bcl-2 expression in each mice tumor tissue. Methods Fifty-five tumor-bearing mice were randomly divided into model group,chemotherapy(CTX) group,low-dose group,low-dose with chemotherapy group and high-dose with chemotherapy group.After treatment,observing the lung surfaces metastasis and bcl-2 protein expressions of each mouse. Results (1) Lung metastases changes:compared with tumor-bearing model,the more than mice lung metastases is statistically significant difference (P<0.05).(2) bcl-2 expression:compared with tumor-bearing model,the more than bcl-2 expression is statistically significant difference (P<0.01). Conclusion Hui medicine Aikangfang can resist lung cancer metastasis in mice and reduce bcl-2 expression.

     

/

返回文章
返回